MUMC+ Wetenschapsdag
On 8 April 2026, the AAV (resident physicians' association) wetenschapsdag took place at MUMC+. On behalf of our department, several posters were presented:
- Pharmacokinetic boosting of osimertinib to improve intracranial disease control in epidermal growth factor receptor (EGFR) mutated Non-Small Cell Lung Cancer (NSCLC) treatment: the OSIBOOST-2B study
Paul Kruithof, Daan Lanser, Maud Salmans, Barend Sikkema, Anne-Marie C Dingemans, Marthe Paats, Gerrina Ruiter, Jasper Smit, Anthonie van der Wekken, Jeroen Hiltermann, Anita Brouns, Ron Mathijssen, Lizza Hendriks, Robin van Geel, Sander Croes
- Prevalence and impact of medication discrepancies across care transitions: A prospective observational cohort study in Dutch hospitals.
Betsie Limmen, Joy van Broekhuizen, Alan Abdulla, Michiel Duyvendak, Linda van Eikenhorst, Karin Hek, Judith de Ruijter-van Dalem, Patricia van den Bemt, Fatma Karapinar
- Real-world medication adherence and medication reviews in adults and children with cystic fibrosis
Lieke Roeke, Liesbeth I van de Ven, Steffie E M Vonk, Jan J M Coremans, Edward Dompeling, Michiel A G E Bannier, Fatma Karapinar-Carkit, Judith de Ruijter – van Dalem
- Secondary data analysis of Adverse Drug Reactions reported by healthcare professionals and patients: interventions to manage ADRs
Sabeth Spronk, Yannick Nielen, Lina Heier, Naomi Jessurun, A. Kant, Fatma Karapinar – Çarkit
- Comparing ChatGPT-4o vs ChatGPT-5.2 in the recall of adverse drug reactions
Zeb van Helden, Rogier van der Zanden, Marielle Slikkerveer, Receb Gündogan, Alan Abdulla, Fatma Karapinar-Çarkit, Annemariek Driessen